Genitourinary Radiology: Page 28

Accuray highlights CyberKnife prostate studies
By AuntMinnie.com staff writers
Radiation oncology firm Accuray is directing attention to two large multicenter studies that evaluated the use of its CyberKnife system for treating low- and intermediate-risk prostate cancer.
September 24, 2018
Ga-68 PSMA-11 PET/MRI advances prostate cancer detection
By Wayne Forrest
PET/MRI scans with a gallium-68 (Ga-68)-labeled radiopharmaceutical that homes in on prostate-specific membrane antigen (PSMA)-11 could become a mainstay in prostate cancer detection, given its ability to significantly outperform multiparametric MRI alone, according to a study published online September 18 in Radiology.
September 24, 2018
2018 09 24 21 13 7781 Ga68 Psma Pet Mri Hicks 20180924220043
Exact Imaging, Cambridge Consultants target prostate cancer
By AuntMinnie.com staff writers
Ultrasound technology developer Exact Imaging has teamed with Cambridge Consultants to improve the visualization and detection of prostate cancer.
September 19, 2018
Prostate MRI coverage varies greatly -- with many caveats
By Wayne Forrest
Insurance coverage for prostate MRI scans varies widely among private payors, requires certain conditions for reimbursement of major conditions, and does not reflect current clinical practice. Those harsh conclusions are contained in a new study published online September 11 in the Journal of the American College of Radiology.
September 12, 2018
2017 06 15 10 31 55 42 Prostate 400
Study warns of PSMA-PET imaging discrepancies
By AuntMinnie.com staff writers
Researchers are warning clinicians about a serious flaw in PET imaging of prostate-specific membrane antigen (PSMA) that could result in a misdiagnosis for prostate cancer, according to a paper published in the September issue of the Journal of Nuclear Medicine.
September 9, 2018
2016 10 04 11 38 34 158 Prostate 400
Contrast US tops CT, MRI for classifying kidney tumors
By AuntMinnie.com staff writers
Contrast-enhanced ultrasound predicted whether suspicious kidney lesions were cancerous more accurately than CT or MRI, according to research presented at the recent Advances in Contrast Ultrasound International Bubble Conference in Chicago.
September 9, 2018
Contrast ultrasound is effective for liver, kidney lesions
By Kate Madden Yee
Contrast-enhanced ultrasound offers an effective, low-cost way to further evaluate hepatic and renal lesions found on ultrasound, and it could be used instead of more expensive imaging modalities for following up patients, according to a study published online August 31 in Ultrasound Quarterly.
September 5, 2018
2016 08 23 17 04 30 620 Kidney 400
Veterans get inappropriate prostate imaging outside VA
By Kate Madden Yee
Veterans who seek care for low-risk prostate cancer receive more imaging that doesn't comply with established guidelines when they go outside of the Veterans Affairs (VA) system to Medicare sources, according to a study published online August 17 in JAMA Network Open.
August 17, 2018
2016 10 04 11 38 34 158 Prostate 400
Can AI best quantitative MRI in prostate lesions?
By Erik L. Ridley
Quantitative measurement of prostate MRI exams can yield better lesion characterization performance than just qualitative assessment by radiologists, German researchers have found. But can machine learning do even better? At least for now, the answer is no, according to a study published online July 31 in Radiology.
August 1, 2018
2016 10 04 11 38 34 158 Prostate 400
MRI finds key indicators of rectal cancer prognosis
By Wayne Forrest
Two key characteristics on MRI scans of rectal cancer patients can help predict long-term survival and local recurrence of the disease, according to a study by researchers from China and published in the August issue of the American Journal of Roentgenology.
July 30, 2018
2018 07 30 19 47 9987 2018 07 31 Rectal Mri B 20180730194615
Multiparametric MRI aids in prostate cancer follow-up
By AuntMinnie.com staff writers
Multiparametric MRI is a valuable option for monitoring patients who have undergone MRI-guided focal laser ablation for prostate cancer, according to a study published online July 11 in the American Journal of Roentgenology.
July 15, 2018
2017 06 15 10 31 55 42 Prostate 400
Augmenix brings SpaceOAR hydrogel to Japan
By AuntMinnie.com staff writers
Prostate radiation therapy device developer Augmenix said the Japanese Ministry of Health, Labor, and Welfare has added the firm's Spacing Organs at Risk (SpaceOAR) hydrogel spacer to the national reimbursement program for all men undergoing prostate cancer radiotherapy in Japan.
July 2, 2018
Previous Page
Page 28 of 93
Next Page